Business
Share Options
Share Options.
About this update from Immupharma Plc
[{"type":"text","content":"\n RNS Number : 7889M Immupharma PLC 04 February 2009 \n \n\n\n\n\nFor Immediate Release\n\n\n4 February 2009\n\n\n\n\n\nImmuPharma PLC\n\nGrant of Options\n\n\nImmuPharma PLC (LSE:IMM), ('ImmuPharma' or the 'Company'), the specialist drug discovery and development company, granted today share options to certain of its employees and Directors. The Company has adopted a HM Revenue & Customs approved share ownership plan (CSOP) and an unapproved share option scheme.\n\nThe amount of options granted are summarised in the following table:\n\n\n\n\n\nDirector\n\n\nOptions Granted\n\n\n\n\nRichard Warr\n\n\n140,000\n\n\n\n\nRobert Zimmer\n\n\n150,000\n\n\n\n\nDimitri Dimitriou\n\n\n140,000\n\n\n\n\nFranco di Muzio\n\n\n100,000\n\n\n\n\nAjay Agrawal\n\n\n100,000\n\n\n\n\n\nThe share options provide the right to subscribe for ordinary shares of 10 pence each in the Company at a price of 86.5 pence each, the closing middle market price on 3 February 2009. The options are exercisable between 3 years and 10 years from the date of grant.\n\n\nFor further information, please contact:\n\nImmuPharma PLC\nDimitri Dimitriou, Chief Executive Officer 020 7152 4080\nRichard Warr, Chairman 020 7152 4080\nDr Robert Zimmer, President & Chief Scientific Officer +33 389 32 76 50\n\nPanmure Gordon & Co (Nominated Advisor and Broker)\nAndrew Burnett / Rakesh Sharma (Corporate Finance) &nbs...